Myers R D, Hepler J R, Holahan W
Peptides. 1983 Jan-Feb;4(1):85-8. doi: 10.1016/0196-9781(83)90171-7.
Previous reports on the effect of anorexigenic peptide (AXP) administered systemically in the rodent are inconsistent in terms of the effect of the tri-peptide on food intake and body weight. The purpose of this study was to examine the effect of AXP infused into the brain on these measures. In post-pubescent female rats of the Sprague-Dawley strain, guide cannulae were permanently implanted in the lateral cerebral ventricle for repeated intracerebroventricular (ICV) infusion. Postoperatively, measures of food and water intake and body weight were obtained every day at the same time. After a 7-day base-line period, AXP was infused bilaterally in a total volume of 15 microliter and in a dose of either 0.25 microgram (n=7) or 1.25 micrograms (n=5), with artificial CSF vehicle serving as the control solution (n=6). ICV infusions were given once daily for 20 consecutive days, after which the same intake and body weight measures were recorded for another 7-day period. The rats given 0.25 micrograms AXP showed a significant suppression in weight gain with the overall slope of the growth curve being 0.358. In contrast, the growth slope of the rats given the 1.25 micrograms dose of AXP was 0.621, whereas those given the CSF was 0.823. Although the trends of intake of food tended to follow the curves of the rats body weight, the difference between g/kg food intake of rats during ICV infusions of either dose of AXP was not significantly different from that of the CSF controls. Water intake also was unaffected by either dose of AXP. These results demonstrate that this tri-peptide derived from urine of patients afflicted with anorexia nervosa exerts a direct effect on the brain. Since the 0.25 micrograms dose of AXP infused acutely ICV caused a sustained hyperthermia, its mechanism of action is apparently a metabolic one; that is, the interruption in the gain in body weight of the rat is independent of the amount of food it ingests.
先前关于在啮齿动物中全身给予厌食肽(AXP)效果的报道,在这种三肽对食物摄入量和体重的影响方面并不一致。本研究的目的是检查脑内注入AXP对这些指标的影响。在斯普拉格 - 道利品系的青春期后雌性大鼠中,将引导套管永久性植入侧脑室,用于重复脑室内(ICV)注入。术后,每天在同一时间获取食物和水摄入量以及体重的测量值。在7天的基线期后,以15微升的总体积双侧注入AXP,剂量为0.25微克(n = 7)或1.25微克(n = 5),以人工脑脊液作为对照溶液(n = 6)。连续20天每天进行一次ICV注入,之后再记录7天相同的摄入量和体重测量值。给予0.25微克AXP的大鼠体重增加受到显著抑制,生长曲线的总体斜率为0.358。相比之下,给予1.25微克剂量AXP的大鼠生长斜率为0.621,而给予脑脊液的大鼠生长斜率为0.823。尽管食物摄入量的趋势倾向于遵循大鼠体重曲线,但在注入任一剂量AXP的ICV期间,大鼠每千克食物摄入量与脑脊液对照组之间的差异无显著统计学意义。水摄入量也不受任一剂量AXP的影响。这些结果表明,这种源自神经性厌食症患者尿液的三肽对大脑有直接作用。由于急性ICV注入0.25微克剂量的AXP会导致持续发热,其作用机制显然是一种代谢机制;也就是说,大鼠体重增加的中断与它摄入的食物量无关。